Bristol Myers Squibb’s proposed $2.3 billion Houston campus is the latest of several U.S. projects planned by global pharmaceutical firms as they seek to increase domestic production and minimize effects of potential trade tariffs.
Bristol Myers Squibb plans $2.3 billion Houston campus
Global drugmakers are expanding domestic production to avoid potential tariffs
By Lou Hirsh
CoStar NewsAugust 10, 2026 | 9:23 P.M.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Companies
- Bristol Myers Squibb
Manufacturing